|
Smallcap
Recap Archives
March, 2005:Bruker BioSciences Corporation...Pharmion Corporation
...Capital Title Group...Unilens Vision...CYOP Systems
-------------------------------------------------------------------------
. . . Achieving goals.
Both operating income and net income have improved in the
fourth quarter 2004 for Bruker BioSciences Corporation
(NASDAQ: BRKR) helping the company achieve its 4th quarter
goals of being profitable and generating positive cash flow.
Recently the company introduced a new highest-performance
ultra-bright X-ray product that improves the brightness and
quality of x-rays. It was part of a number of recent product
introductions and improvements in its core specialities of
x-ray technology and mass spectrometry.
. . . A recent episode of
the medical drama House featured thalidomide as
a life-saving antidote for a dying boy. It underscored the
turnaround of the drug from its fearful reputation to one
of hope in the treatment of myeloma and its potential for
treating AIDS, tuberculosis, and other illnesses. Thalidmide
is one of the products that has helped power Pharmion Corporation
to fourth quarter net sales of $51.5 million in 2004, compared
to $11.8 million in the fourth quarter of 2003.
. . . Record revenue.
Capital Title Group
(Nasdaq: CTGI), which offers title insurance and related services
to the real estate industry, declared a quarterly cash dividend
of $.02 per common share. It probably helped that a few days
ago, Capital reported a record level of revenue, $290.9 million
for 2004, growing 16.2% over the previous year. With the acquisition
of Nationwide Appraisal in May, Capital gained access to the
national real estate market.
. . . Baby boomer earnings.
The main reason behind the 124% rise in earnings for Unilens
Vision (UVICF.OB) in the first half of fiscal year 2005
appears to be royalty income from Bausch & Lomb. Bausch
& Lomb licenses one of the company's multifocal designs.
The strong demand for multifocal lens is another baby boomer
stock effect (which will continue for quite awhile). With
multifocal contact lenses, aging baby boomers don't need glasses
over their lenses for close-up reading. Recently, Unilens
acquired the Aquaflex and Softcon EW soft contact lens product
lines from CIBA Vision Corporation, the eye care unit of Novartis
AG.
. . . The games people play.
And increasingly, they're playing online. To better take advantage
of the online gaming trend, Wasinger Tech, which operates
a portal (www.ewoss.com) that attracts millions of online
users monthly, is licensing Pay for Play software from CYOP
Systems (OTCBB:CYOS). CrediPlay, CYOP's licensed software
application, is an online transaction platform that is based
on charging a fee for each game of skill played over the Internet.
|
